New User:
-or-
Username:
Password:
Forgot your password?
News Breaks
16:00 EDTARAY
theflyonthewall.com: Accuray sees FY10 revenue in-line with consensus
Accuray's (ARAY) CEO Euan S. Thomson is optimistic about the growth of the company's main product line, CyberKnife. Since the CyberKnife has moved into extra-cranial radiation treatment from intra-cranial, the product has gained momentum. It is now being used as the preferred treatment for lung, prostate and breast cancer. Thomson sees Europe as the fastest growing market going forward, with other countries emerging from the recession at different rates. He forecasts FY10 revenue of $215M-$230M vs. consensus estimates of $222.88M. These comments were made on the Accuray Investor and Analyst Meeting. :theflyonthewall.com



News For ARAY From The Last 14 Days
Check below for free stories on ARAY the last two weeks.
There are 3 items on the Fly with pertinent information.
Sign up for a free trial to see the rest of the stories you've been missing.
February 8, 2010
06:15 EDTARAY
theflyonthewall.com: Accuray upgraded to Buy from Hold at Jefferies
Jefferies upgraded Accuray citing new order momentum which indicates accelerated demand for SRS technology. Target to $8 from $6.50. :theflyonthewall.com

February 4, 2010
16:28 EDTARAY
theflyonthewall.com: Accuray sees FY10 sales $220M-$230M vs. previous outlook $215M-$230M

Subscribe for More Information :theflyonthewall.com
16:27 EDTARAY
theflyonthewall.com: Accuray reports Q2 EPS (2c) vs. consensus of (1c)

Subscribe for More Information :theflyonthewall.com